Literature DB >> 22252813

In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010.

Guillermo V Sanchez1, Ronald N Master, James A Karlowsky, Jose M Bordon.   

Abstract

This study examines in vitro antimicrobial resistance data from Escherichia coli isolates obtained from urine samples of U.S. outpatients between 2000 and 2010 using The Surveillance Network (TSN). Antimicrobial susceptibility results (n = 12,253,679) showed the greatest increases in E. coli resistance from 2000 to 2010 for ciprofloxacin (3% to 17.1%) and trimethoprim-sulfamethoxazole (TMP-SMX) (17.9% to 24.2%), whereas nitrofurantoin (0.8% to 1.6%) and ceftriaxone (0.2% to 2.3%) showed minimal change. From 2000 to 2010, the antimicrobial resistance of urinary E. coli isolates to ciprofloxacin and TMP-SMX among outpatients increased substantially.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22252813      PMCID： PMC3318377          DOI： 10.1128/AAC.06060-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database--USA.

Authors:  D F Sahm; M K Marsilio; G Piazza
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Antimicrobial resistance trends and outbreak frequency in United States hospitals.

Authors:  Daniel J Diekema; Bonnie J BootsMiller; Thomas E Vaughn; Robert F Woolson; Jon W Yankey; Erika J Ernst; Stephen D Flach; Marcia M Ward; Carrie L J Franciscus; Michael A Pfaller; Bradley N Doebbeling
Journal:  Clin Infect Dis       Date:  2003-12-08       Impact factor: 9.079

3.  Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy.

Authors:  Thomas M Hooton; Richard Besser; Betsy Foxman; Thomas R Fritsche; Lindsay E Nicolle
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

4.  Current antibiotic therapy for isolated urinary tract infections in women.

Authors:  Alexander J Kallen; H Gilbert Welch; Brenda E Sirovich
Journal:  Arch Intern Med       Date:  2006-03-27

5.  Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

Authors:  George G Zhanel; Tamiko L Hisanaga; Nancy M Laing; Melanie R DeCorby; Kim A Nichol; Barb Weshnoweski; Jack Johnson; Ayman Noreddin; Don E Low; James A Karlowsky; Daryl J Hoban
Journal:  Int J Antimicrob Agents       Date:  2006-05-18       Impact factor: 5.283

6.  Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals.

Authors:  Conan MacDougall; J Patrick Powell; Christopher K Johnson; Michael B Edmond; Ronald E Polk
Journal:  Clin Infect Dis       Date:  2005-06-28       Impact factor: 9.079

7.  Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

Authors:  Marcus J Zervos; Ellie Hershberger; David P Nicolau; David J Ritchie; Lori K Blackner; Elizabeth A Coyle; Andrew J Donnelly; Stephen F Eckel; Robert H K Eng; Alexandra Hiltz; Arpi G Kuyumjian; William Krebs; Angee McDaniel; Patricia Hogan; Teresa J Lubowski
Journal:  Clin Infect Dis       Date:  2003-11-20       Impact factor: 9.079

8.  Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.

Authors:  Luke Johnson; Allison Sabel; William J Burman; Rachel M Everhart; Marcie Rome; Thomas D MacKenzie; Jeanne Rozwadowski; Philip S Mehler; Connie Savor Price
Journal:  Am J Med       Date:  2008-10       Impact factor: 4.965

9.  Stratified analysis of multidrug-resistant Escherichia coli in US health care institutions.

Authors:  Daniel F Sahm; Nina P Brown; Y Cheung Yee; Alan T Evangelista
Journal:  Postgrad Med       Date:  2008-09       Impact factor: 3.840

10.  Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.

Authors:  Mark E Jones; James A Karlowsky; Deborah C Draghi; Clyde Thornsberry; Daniel F Sahm; Dilip Nathwani
Journal:  Int J Antimicrob Agents       Date:  2004-03       Impact factor: 5.283
View more
  67 in total

1.  In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.

Authors:  James A Karlowsky; Heather J Adam; Melanie R Baxter; Andrew J Denisuik; Philippe R S Lagacé-Wiens; Andrew J Walkty; Sailaja Puttagunta; Michael W Dunne; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study.

Authors:  James A Karlowsky; Andrew J Denisuik; Philippe R S Lagacé-Wiens; Heather J Adam; Melanie R Baxter; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

3.  Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System.

Authors:  Haley J Morrill; Jacob B Morton; Aisling R Caffrey; Lan Jiang; David Dosa; Leonard A Mermel; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections.

Authors:  Ansal Shah; Julie Ann Justo; P Brandon Bookstaver; Joseph Kohn; Helmut Albrecht; Majdi N Al-Hasan
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 5.  Diagnosis of Urinary Tract Infections in Children.

Authors:  Christopher D Doern; Susan E Richardson
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

6.  Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment.

Authors:  Sibhghatulla Shaikh; Jamale Fatima; Shazi Shakil; Syed Mohd Danish Rizvi; Mohammad Amjad Kamal
Journal:  Saudi J Biol Sci       Date:  2014-08-17       Impact factor: 4.219

7.  Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018.

Authors:  Marya D Zilberberg; Brian H Nathanson; Kate Sulham; Andrew F Shorr
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

Review 8.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

9.  Long-term prescribing of nitrofurantoin for urinary tract infections (UTI) in veterans with spinal cord injury (SCI).

Authors:  Alexander B Chew; Katie J Suda; Ursula C Patel; Margaret A Fitzpatrick; Swetha Ramanathan; Stephen P Burns; Charlesnika T Evans
Journal:  J Spinal Cord Med       Date:  2018-07-09       Impact factor: 1.985

10.  Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance.

Authors:  Sangeeta Sastry; Lloyd G Clarke; Hind Alrowais; Ashley M Querry; Kathleen A Shutt; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.